Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma

被引：5
|
作者：
Shi, Yang [1 ,2 ]
Xiang, Zheng [4 ]
Yang, Huiyu [1 ,2 ]
Khan, Suliman [5 ]
Li, Ruizhe [3 ]
Zhou, Siran [1 ,2 ]
Ullah, Saif [1 ,2 ]
Zhang, Jiyu [1 ,2 ]
Liu, Bingrong [1 ,2 ]
机构：
[1] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China
[4] Zhengzhou Univ, Henan Univ, Henan Prov Peoples Hosp, Dept Pathol,Peoples Hosp, Zhengzhou 450003, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou 450000, Peoples R China
来源：
AGING-US | 2021年 / 13卷 / 11期
基金：
中国国家自然科学基金;
关键词：
histone deacetylase inhibitors; LMK-235; esophageal squamous cell carcinoma; tensin-3; histone acetylation; SRC FAMILY KINASES; HDAC INHIBITORS; PROTEIN; EPIGENETICS; COMBINATION; EXPRESSION; PACKAGE;
D O I：
10.18632/aging.203091
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Histone acetylation which regulates about 2-10% of genes has been demonstrated to be involved in tumorigenesis of esophageal squamous cell carcinoma (ESCC). In this study, we investigated the treatment response of ESCC to selective histone deacetylase inhibitor (HDACi) LMK-235 and potential biomarker predicting the treatment sensitivity. We identified tensin-3 (TNS3) which was highly over-expressed in ESCC as one of the down-regulated genes in response to LMK-235 treatment. TNS3 was found positively correlated with the tumor malignancy and poor prognosis in the patients. Silencing TNS3 significantly inhibited ESCC cell proliferation both in vitro and in vivo, sensitizing the treatment response to LMK-235. Our findings provide an insight into understanding the oncogenic role of TNS3 in ESCC and its clinical application for HDAC targeted therapy of ESCC.
引用
收藏
页码：15336 / 15352
页数：17
相关论文
共 50 条
  • [31] Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma
    Bai, Li-Yuan
    Chiu, Chang-Fang
    Pan, Shiow-Lin
    Sargeant, Aaron M.
    Shieh, Tzong-Ming
    Wang, Ying-Chu
    Weng, Jing-Ru
    ORAL ONCOLOGY, 2011, 47 (12) : 1127 - 1133
  • [32] Re: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
    Samid, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) : 475 - 476
  • [33] Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma
    Li F.
    Zhang J.
    Ma C.
    Wang Z.
    Li Y.
    Zhao J.
    Liu K.
    Current Pharmacology Reports, 2020, 6 (6) : 415 - 428
  • [34] Targeting Aberrant Histone Posttranscription Modification Machinery in Esophageal Squamous Cell Carcinoma: Current Findings and Challenges
    Ma, Gang
    Gong, Tongyang
    Liu, Zhihua
    RESEARCH, 2022, 2022
  • [35] A NEW DOUBLE-EFFECT THERAPEUTIC STRATEGY USING A HISTONE DEACETYLASE INHIBITOR FOR HCV-ASSOCIATED HEPATOCELLULAR CARCINOMA
    Genka, A.
    Satoh, I.
    Fukuda, S.
    Nagami, S.
    Muramatsu, T.
    Saito, Y.
    Sugiyama, K.
    Saito, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S477 - S477
  • [36] Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma
    Shen, Lu-Yan
    Zhou, Ting
    Du, Ya-Bing
    Shi, Qi
    Chen, Ke-Neng
    CANCER SCIENCE, 2019, 110 (05) : 1735 - 1745
  • [37] Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
    Jaime-Ramirez, Alena C.
    Yu, Jun-Ge
    Caserta, Enrico
    Yoo, Ji Young
    Zhang, Jianying
    Lee, Tae Jin
    Hofmeister, Craig
    Lee, John H.
    Kumar, Bhavna
    Pan, Quintin
    Kumar, Pawan
    Baiocchi, Robert
    Teknos, Theodoros
    Pichiorri, Flavia
    Kaur, Balveen
    Old, Matthew
    MOLECULAR THERAPY-ONCOLYTICS, 2017, 5 : 87 - 96
  • [38] Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy
    Maruyama, K.
    Motoyama, S.
    Anbai, A.
    Usami, S.
    Sato, Y.
    Shibuya, K.
    Yoshino, K.
    Nakatsu, T.
    Minamiya, Y.
    Ogawa, J. -I.
    DISEASES OF THE ESOPHAGUS, 2011, 24 (03) : 166 - 171
  • [39] PS-341 and Histone Deacetylase Inhibitor Synergistically Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
    Kim, JinKoo
    Guan, Jean
    Chang, Insoon
    Chen, Xiaohong
    Han, Demin
    Wang, Cun-Yu
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) : 1977 - 1984
  • [40] Re: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase - Reply
    Warrell, RP
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) : 476 - 476
12345